SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2022

SEGMENT REPORTING

Schedule of business segments

	Cure			Sera  Labs			Eliminations			Consolidated
Net Sales	$	40		$	1,076		$	(13	)	$	1,103
Operating Loss	$	(873	)	$	(1,158	)	$	-		$	(2,031	)
Assets	$	44,450		$	7,049		$	(14,175	)	$	37,324
Accounts receivable, net	$	-		$	469		$	-		$	469
Inventory, net	$	260		$	526		$	-		$	786
Interest expense	$	173		$	23		$	-		$	196
Depreciation and amortization	$	421		$	578					$	999
Impairment of goodwill	$	2,728		$	-		$	-		$	2,728

	Cure			Sera Labs			Eliminations			Consolidated
Net Sales	$	194		$	1,260		$	(9	)	$	1,445
Operating Loss	$	(2,816	)	$	(1,674	)	$	-		$	(4,499	)
Assets	$	45,767		$	12,588		$	(14,175	)	$	44,180
Accounts receivable, net	$	151		$	117		$	-		$	268
Inventory, net	$	342		$	461		$	-		$	803
Interest expense	$	64		$	3		$	-		$	67
Depreciation and amortization	$	86		$	577		$	-		$	663
Impairment of goodwill	$	-		$	-		$	-		$	-

Schedule of disaggregation of revenue

	Three Months Ended March 31,
	2022			2021
CureFilm™ sales		12	%		11	%
Cosemtic sales – Revolution Line		14	%		0	%
Product sales - CBD		73	%		85	%
Total		99	%		96	%